3 hours Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of “Buy” from Analysts MarketBeat
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has received a consensus rating of “Buy” from the eight analysts that are presently covering the firm, Marketbeat.com reports. Eight analysts have rated the stock with a buy rating. The average 12-…